AI-Guided (GenAIS TM) Versus Standard Physician-Guided Dietary Supplementation for Managing Metabolic Syndrome

S.LAB (SOLOWAYS)

Status

Completed

Conditions

Metabolic Syndrome

Treatments

Other: AI-Guided Group

Other: Standard therapy group

Study type

Interventional

Funder types

Other

Identifiers

NCT06470399

SW017

Details and patient eligibility

About

The study "AI-Guided (GenAIS TM) Versus Standard Physician-Guided Dietary Supplementation for Managing Metabolic Syndrome" aimed to compare the effectiveness of AI-guided dietary supplement (DS) prescriptions versus standard physician-guided prescriptions in managing metabolic syndrome. This 6-month randomized controlled trial included 160 participants diagnosed with metabolic syndrome. Participants were divided into two groups: one received DS based on physician judgment, and the other based on GenAIS AI system analysis. Primary outcomes focused on changes in metabolic parameters, while secondary outcomes included individual components of metabolic syndrome, inflammation levels, body weight, and adherence to the DS regimen. Data collection involved genetic, metabolic, and clinical profiling, with ethical considerations ensuring participant confidentiality and informed consent.

Enrollment

160 patients

Sex

All

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age between 40 and 75 years.
Diagnosed with metabolic syndrome, defined by the presence of at least three of the following criteria:
Waist circumference > 102 cm (men) or > 88 cm (women).
Triglycerides ≥ 150 mg/dL.
HDL cholesterol < 40 mg/dL (men) or < 50 mg/dL (women).
Blood pressure ≥ 130/85 mm Hg.
Fasting glucose ≥ 100 mg/dL. • Willingness to provide genetic and metabolic data.

Exclusion criteria

Significant renal, hepatic, or cardiovascular diseases.
Use of dietary supplements that affect metabolic parameters within the last 3 months.
Pregnancy or breastfeeding.